These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 903183)

  • 21. [Effects of mTOR Inhibitor Rapamycin on Burkitt's Lymphoma Cells].
    Zhou LH; Zhu XP; Xiao HF; Xin PL; Li CT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1397-1405. PubMed ID: 29070114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt's lymphoma.
    Pearson GR; Qualtiere LF; Klein G; Norin T; Bal IS
    Int J Cancer; 1979 Oct; 24(4):402-6. PubMed ID: 93578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma.
    Rowe M; Rooney CM; Edwards CF; Lenoir GM; Rickinson AB
    Int J Cancer; 1986 Mar; 37(3):367-73. PubMed ID: 3005176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB).
    Gravell M; Levine PH; McIntyre RF; Land VJ; Pagano JS
    J Natl Cancer Inst; 1976 Apr; 56(4):701-4. PubMed ID: 176407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host defence mechanisms in Burkitt's lymphoma and Kaposi's sarcoma: the clinical evidence.
    Burkitt DP
    Br Med J; 1970 Nov; 4(5732):424-6. PubMed ID: 5481523
    [No Abstract]   [Full Text] [Related]  

  • 26. Complement receptor expression by neoplastic and normal human cells.
    Gaither TA; Magrath IT; Berger M; Hammer CH; Novikovs L; Santaella M; Frank MM
    J Immunol; 1983 Aug; 131(2):899-905. PubMed ID: 6306108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age and sex as factors influencing remission duration in African Burkitt's lymphoma.
    Biggar RJ; Gail MH; Banks RB; Neequaye J; Nkrumah FK
    Am J Epidemiol; 1982 Oct; 116(4):668-77. PubMed ID: 7137153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Maxillofacial location of Burkitt's lymphoma in children treated at the University Hospital Center in Bamako, Mali: a 24-case series].
    Togo B; Keita M; Medefo D; Traore F; Sidibe T
    Med Trop (Mars); 2008 Dec; 68(6):600-2. PubMed ID: 19639827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas.
    Payne CM; Grogan TM; Cromey DW; Bjore CG; Kerrigan DP
    Lab Invest; 1987 Aug; 57(2):200-18. PubMed ID: 3497304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse.
    Appelbaum FR; Deisseroth AB; Graw RG; Herzig GP; Levine AS; Magrath IT; Pizzo PA; Poplack DG; Ziegler JL
    Cancer; 1978 Mar; 41(3):1059-63. PubMed ID: 638947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research on the relationship between artesunate and Raji cell autophagy and apoptosis of Burkitt's lymphoma and its mechanism.
    Wang ZC; Liu Y; Wang H; Han QK; Lu C
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2238-2243. PubMed ID: 28537658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human peripheral gamma delta T cells are stimulated by Daudi Burkitt's lymphoma and not by any other Burkitt's lymphoma tested.
    Kaur I; de Jong J; Schell K; Hank J; Fisch P; Sondel PM
    Cell Immunol; 1994 Jun; 156(1):54-61. PubMed ID: 8200042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppression in Burkitt's lymphoma. II. Peripheral blood lymphocyte populations related to clinical status.
    Magrath IT; Simon RM
    Int J Cancer; 1976 Oct; 18(4):399-408. PubMed ID: 977186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burkitt's lymphoma and HL-A antigens.
    Dick HM; Steel CM; Levin AG; Henderson N
    Tissue Antigens; 1975 Feb; 5(1):52-8. PubMed ID: 1138442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
    Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
    Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus integrates frequently into chromosome 4q, 2q, 1q and 7q of Burkitt's lymphoma cell line (Raji).
    Gao J; Luo X; Tang K; Li X; Li G
    J Virol Methods; 2006 Sep; 136(1-2):193-9. PubMed ID: 16806502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.
    Jondal M; Gunven P
    Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a glycosyl-phosphatidylinositol anchor-deficient subline of Raji cells. An analysis of the functional importance of complement inhibitors on the Raji cell line.
    Harris CL; Morgan BP
    Immunology; 1995 Oct; 86(2):311-8. PubMed ID: 7490134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.
    Wiels J; Lenoir GM; Fellous M; Lipinski M; Salomon JC; Tetaud C; Tursz T
    Int J Cancer; 1982 Jun; 29(6):653-8. PubMed ID: 6286514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.